Suchergebnisse - "Lambert, Jo"

PubPharm (251)

1

Best Practice for Therapeutic Drug Monitoring of Infliximab : Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

enthalten in: Therapeutic drug monitoring | 2024

von Alsoud, D. | Moes, D. | Wang, Z. | +14

2

GDF15 mediates inflammation-associated bone loss through a brain-bone axis

enthalten in: ResearchSquare.com | 2024

von Elewaut, D. | Cruyssen, R. | Devan, J. | +29

3

Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic Modeling

enthalten in: The Journal of investigative dermatology | 2024

von van Huizen, A. | Bank, P. | van der Kraaij, G. | +12

4

Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis : A subset analysis of two phase 3 randomized trials in plaque psoriasis

enthalten in: Journal of the American Academy of Dermatology | 2024

von Blauvelt, A. | Rich, P. | Sofen, H. | +11

5

Beyond visual inspection : The value of infrared thermography in skin diseases, a scoping review

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Speeckaert, R. | Hoorens, I. | Lambert, J. | +2

6

Freedom from disease in plaque psoriasis : Comparing the perceived importance of voting round 2 statements from a Delphi consensus of patients, physicians and nurses

enthalten in: Journal of the European Academy of Dermatology and Venereology | 2024

von Ee, I. | Deprez, E. | Egeberg, A. | +11

7

Freedom from disease in plaque psoriasis : Comparing the perceived importance of voting round 2 statements from a Delphi consensus of patients, physicians and nurses

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von van Ee, I. | Deprez, E. | Egeberg, A. | +11

8

GDF15 mediates inflammation-associated bone loss through a brain-bone axis

enthalten in: bioRxiv.org | 2023

von Van der Cruyssen, R. | Devan, J. | Heggli, I. | +29

9

Correction to : Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel

enthalten in: Dermatology and therapy | 2023

von Papp, K. | Melosky, B. | Sehdev, S. | +12

ErratumFor: Dermatol Ther (Heidelb). 2023 Apr;13(4):867-889. - PMID 36929121

10

Correction to : Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study

enthalten in: Advances in therapy | 2023

von Ghislain, P. | Lambert, J. | Lam Hoai, X. | +4

ErratumFor: Adv Ther. 2022 Feb;39(2):1068-1080. - PMID 34977985

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]